IDO1 and neoplasm: One such factor may be indoleamine 2,3-dioxygenase (IDO), which exhibits inhibitory effects on T cell activity and proliferation, and can lead to tumor growth and metastasis, as well as a reduction in the efficacy of the administered vaccine [114].